I. Moya

RNA-Based Multiplexing Assay for Routine Testing of Fusion and Splicing Variants in Cytological Samples of NSCLC Patients

A. Giménez-Capitán, M. Molina-Vila, S. Viteri, 2020, Diagnostics.

Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer

R. Rosell, N. Viñolas, A. Prat, 2020, Molecular oncology.

Analysis of Copy Number Variations in Solid Tumors Using a Next Generation Sequencing Custom Panel

R. Rosell, F. Pons, M. Molina, 2021, Journal of Molecular Pathology.

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.

Irene Moya, Á. Casalots, C. Pericay, 2013, Oncology reports.

Role of chemoradiotherapy alone in the management of unfit patients with nonmetastatic locally advanced squamous cell carcinoma of the esophagus.

C. Pericay, S. Navarro, A. Alvarado, 2011, Journal of Clinical Oncology.

The GAIN-C study (BP25438): Randomized phase II trial of RG7160 (GA201) plus FOLFIRI, compared to cetuximab plus FOLFIRI or FOLFIRI alone in second-line KRAS wild type (WT) or mutant metastatic colorectal cancer (mCRC).

J. Tabernero, J. Bridgewater, B. Markman, 2012 .